Phosphothiophene and phosphothiazole HCV polymerase inhibitors
US8193372B2 · kind B2 · utility
21Cited by
8References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2010 |
| Grant date | Jun 5, 2012 |
| Priority date | — |
| Expiry date | Jun 2, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65586
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are phosphothiophene and phosphothiazole compounds, for example, of any of Formulae I, IA, IIA, IIIA, IVA, VA, VIA, VIIA, IB, IIB, IIIB, IVB, VB, VIB and VIIB disclosed herein, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host infected with HCV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.